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in its mission statement—“To advance and promote the sciences relevant to skin health and disease through education, 
advocacy, and scholarly exchange of scien-
tific information”—the Society for Investigative 
Dermatology (SID) asks each of its members to 
engage in activities that advance the research 
and study of skin disease. For most of us, the 
activities of education, scholarly work, and 
exchange of scientific information come natu-
rally as a product of our daily professional 
activities. However, the avenues to effect advo-
cacy are not quite as obvious. For the efforts of 
our Society to flourish and succeed, we must 
advocate for ongoing and generous public sup-
port of our research and educational efforts 
at the undergraduate, graduate, professional, 
postgraduate, and fellowship levels. To achieve 
these goals, assistance from and interaction 
with much larger organized bodies is required.
For many years, the SID has maintained 
a voice within organized medicine by send-
ing representatives to the House of Delegates 
of the American Medical Association (AMA). 
The voice of our small organization has been 
amplified by collaboration with the American 
Academy of Dermatology and the American 
Society for Dermatologic Surgery, and soon it 
will be joined by the American College of Mohs 
Surgery. The missions of these organizations are 
parallel to ours. Participation in the governing 
functions of the AMA is a natural extension of 
the advocacy activities of the SID. Although the 
AMA is not the unified Voice of Medicine, it 
represents the only unified voice within medi-
cine. The AMA’s mission—“To promote the art 
and science of medicine and the betterment of 
public health”—parallels that of the SID.
Recent AMA House of Delegates actions on 
issues of importance to the SID’s membership 
have included publishing position statements 
on NIH funding and graduate medical 
education issues, which include continuing 
medical education requirements, appropriate 
interactions with the pharmaceutical industry, 
conduct of recertification exams, residency 
work hours, and physician ethics. Although 
none of the actions or decisions of the AMA’s 
House of Delegates has the impact of law, 
these positions do affect US legislative and 
executive decisions.
At the 2009 AMA House of Delegates in June, 
President Obama said, “One thing we need to 
do is figure out what works, and encourage 
rapid implementation of what works into your 
practices. That’s why we are making a major 
investment in research to identify the best treat-
ments for a variety of ailments and conditions.” 
The intention of the president’s speech was to 
enlist the aid of all in medicine in achieving 
solutions to what he feels is a broken system. In 
his speech, President Obama made three refer-
ences to medical research. Medical education 
received one mention, and that was in the con-
text of encouraging increased training in the 
primary care specialties. Those in the executive 
and legislative branches of government must, 
through our advocacy, reach a broader view of 
the scope of medicine.
Health-care reform is undoubtedly the single 
most important issue affecting the practice of 
medicine in the United States at present. Any 
reform efforts are certain to impact the clini-
cal practice of dermatology and the finances of 
academic departments nationwide. The SID is a 
small organization within a small specialty, but 
our representation within the AMA provides an 
opportunity to expand our reach by building 
upon connections within the dermatology del-
egation as well as among other delegates con-
cerned with medical research and education.
SID members must loudly voice that research 
that can be immediately brought to the bedside 
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MDs, PhDs, or other professionals, we are all committed 
to the same goals. We must begin by making certain that 
as individuals we are informed and our informed views 
are expressed; then, we must work collectively through the 
AMA, the SID, and sibling societies. Through advocacy we 
can help to ensure that real and beneficial advances will be 
fostered and funded.
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is important and that increased and sustained funding of basic 
research is essential to our ultimate success in the medical sci-
ences. Our educational activities train not only the researchers 
and clinicians of dermatology but also all those in medicine 
and the clinical sciences, including those who will become 
the primary care specialists so integral to President Obama’s 
proposed health-care reform program.
Patient care begins at the bench; each success at the 
bench can only enhance efficiency at the bedside. Likewise, 
the basic research work of academic programs is facilitated 
by vibrant, successful, and efficient clinical programs. The 
development of new therapies, devices, techniques, and 
drugs depends on what the members of the SID can bring to 
the fundamental understanding of skin function and disease.
Globally, investigators and researchers should be seen and 
heard. We must become vocal advocates for our science, 
our patients, our profession, and our specialties. Whether 
